vs

Side-by-side financial comparison of Installed Building Products, Inc. (IBP) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Installed Building Products, Inc. is the larger business by last-quarter revenue ($747.5M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Installed Building Products, Inc. runs the higher net margin — 10.2% vs 6.8%, a 3.4% gap on every dollar of revenue. On growth, Installed Building Products, Inc. posted the faster year-over-year revenue change (-0.4% vs -1.7%). Over the past eight quarters, Installed Building Products, Inc.'s revenue compounded faster (3.9% CAGR vs -0.1%).

Installed Building Products, Inc. is a leading US-based provider of professional installation services for building products. Core offerings include insulation, gutters, garage doors, fire protection systems and window treatments, serving residential new construction, repair & remodel, and commercial construction segments across most US regions.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

IBP vs MD — Head-to-Head

Bigger by revenue
IBP
IBP
1.5× larger
IBP
$747.5M
$493.8M
MD
Growing faster (revenue YoY)
IBP
IBP
+1.4% gap
IBP
-0.4%
-1.7%
MD
Higher net margin
IBP
IBP
3.4% more per $
IBP
10.2%
6.8%
MD
Faster 2-yr revenue CAGR
IBP
IBP
Annualised
IBP
3.9%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBP
IBP
MD
MD
Revenue
$747.5M
$493.8M
Net Profit
$76.6M
$33.7M
Gross Margin
35.0%
Operating Margin
14.6%
9.9%
Net Margin
10.2%
6.8%
Revenue YoY
-0.4%
-1.7%
Net Profit YoY
14.5%
10.5%
EPS (diluted)
$2.81
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBP
IBP
MD
MD
Q4 25
$747.5M
$493.8M
Q3 25
$778.2M
$492.9M
Q2 25
$760.3M
$468.8M
Q1 25
$684.8M
$458.4M
Q4 24
$750.2M
$502.4M
Q3 24
$760.6M
$511.2M
Q2 24
$737.6M
$504.3M
Q1 24
$692.9M
$495.1M
Net Profit
IBP
IBP
MD
MD
Q4 25
$76.6M
$33.7M
Q3 25
$74.4M
$71.7M
Q2 25
$69.0M
$39.3M
Q1 25
$45.4M
$20.7M
Q4 24
$66.9M
$30.5M
Q3 24
$68.6M
$19.4M
Q2 24
$65.2M
$-153.0M
Q1 24
$55.9M
$4.0M
Gross Margin
IBP
IBP
MD
MD
Q4 25
35.0%
Q3 25
34.0%
Q2 25
34.2%
Q1 25
32.7%
Q4 24
33.6%
Q3 24
33.8%
Q2 24
34.1%
Q1 24
33.8%
Operating Margin
IBP
IBP
MD
MD
Q4 25
14.6%
9.9%
Q3 25
13.7%
13.8%
Q2 25
13.3%
12.8%
Q1 25
10.2%
7.0%
Q4 24
13.1%
7.8%
Q3 24
13.3%
6.6%
Q2 24
12.9%
-31.3%
Q1 24
12.7%
3.2%
Net Margin
IBP
IBP
MD
MD
Q4 25
10.2%
6.8%
Q3 25
9.6%
14.5%
Q2 25
9.1%
8.4%
Q1 25
6.6%
4.5%
Q4 24
8.9%
6.1%
Q3 24
9.0%
3.8%
Q2 24
8.8%
-30.3%
Q1 24
8.1%
0.8%
EPS (diluted)
IBP
IBP
MD
MD
Q4 25
$2.81
$0.40
Q3 25
$2.74
$0.84
Q2 25
$2.52
$0.46
Q1 25
$1.64
$0.24
Q4 24
$2.39
$0.37
Q3 24
$2.44
$0.23
Q2 24
$2.30
$-1.84
Q1 24
$1.97
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBP
IBP
MD
MD
Cash + ST InvestmentsLiquidity on hand
$321.9M
$375.2M
Total DebtLower is stronger
$886.6M
$570.5M
Stockholders' EquityBook value
$709.9M
$865.9M
Total Assets
$2.1B
$2.2B
Debt / EquityLower = less leverage
1.25×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBP
IBP
MD
MD
Q4 25
$321.9M
$375.2M
Q3 25
$333.3M
$340.1M
Q2 25
$305.2M
$224.7M
Q1 25
$298.7M
$99.0M
Q4 24
$327.6M
$229.9M
Q3 24
$406.2M
$103.8M
Q2 24
$380.3M
$19.4M
Q1 24
$399.9M
$8.0M
Total Debt
IBP
IBP
MD
MD
Q4 25
$886.6M
$570.5M
Q3 25
$880.8M
$577.2M
Q2 25
$876.1M
$583.9M
Q1 25
$872.4M
$590.5M
Q4 24
$874.8M
$597.1M
Q3 24
$872.3M
Q2 24
$875.8M
Q1 24
$875.0M
Stockholders' Equity
IBP
IBP
MD
MD
Q4 25
$709.9M
$865.9M
Q3 25
$678.6M
$890.7M
Q2 25
$664.5M
$833.8M
Q1 25
$660.9M
$789.2M
Q4 24
$705.3M
$764.9M
Q3 24
$716.4M
$732.5M
Q2 24
$685.3M
$706.5M
Q1 24
$679.2M
$856.2M
Total Assets
IBP
IBP
MD
MD
Q4 25
$2.1B
$2.2B
Q3 25
$2.1B
$2.2B
Q2 25
$2.0B
$2.1B
Q1 25
$2.0B
$2.0B
Q4 24
$2.1B
$2.2B
Q3 24
$2.1B
$2.1B
Q2 24
$2.0B
$2.0B
Q1 24
$2.0B
$2.2B
Debt / Equity
IBP
IBP
MD
MD
Q4 25
1.25×
0.66×
Q3 25
1.30×
0.65×
Q2 25
1.32×
0.70×
Q1 25
1.32×
0.75×
Q4 24
1.24×
0.78×
Q3 24
1.22×
Q2 24
1.28×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBP
IBP
MD
MD
Operating Cash FlowLast quarter
$64.9M
$114.1M
Free Cash FlowOCF − Capex
$49.3M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.85×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$300.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBP
IBP
MD
MD
Q4 25
$64.9M
$114.1M
Q3 25
$124.0M
$137.3M
Q2 25
$90.4M
$137.2M
Q1 25
$92.1M
$-117.5M
Q4 24
$74.8M
$133.0M
Q3 24
$101.4M
$91.8M
Q2 24
$79.0M
$107.0M
Q1 24
$84.8M
$-125.2M
Free Cash Flow
IBP
IBP
MD
MD
Q4 25
$49.3M
Q3 25
$104.8M
Q2 25
$74.8M
Q1 25
$71.9M
Q4 24
$52.9M
Q3 24
$77.3M
Q2 24
$58.2M
Q1 24
$63.0M
FCF Margin
IBP
IBP
MD
MD
Q4 25
6.6%
Q3 25
13.5%
Q2 25
9.8%
Q1 25
10.5%
Q4 24
7.1%
Q3 24
10.2%
Q2 24
7.9%
Q1 24
9.1%
Capex Intensity
IBP
IBP
MD
MD
Q4 25
2.1%
Q3 25
2.5%
Q2 25
2.1%
Q1 25
2.9%
Q4 24
2.9%
Q3 24
3.2%
Q2 24
2.8%
Q1 24
3.1%
Cash Conversion
IBP
IBP
MD
MD
Q4 25
0.85×
3.39×
Q3 25
1.67×
1.91×
Q2 25
1.31×
3.49×
Q1 25
2.03×
-5.66×
Q4 24
1.12×
4.36×
Q3 24
1.48×
4.72×
Q2 24
1.21×
Q1 24
1.52×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBP
IBP

Residential New Construction$488.6M65%
Other Customer Installation$67.8M9%
Shower Doors Shelving And Mirrors$53.5M7%
Other Building Products$47.7M6%
Fireproofing And Firestopping$37.6M5%
Rain Gutters$31.3M4%
Window Blinds$18.0M2%
Related Party$6.7M1%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons